Search All News
Opening remarks were delivered by Dr. Blair Simpson, interim chair of psychiatry at Columbia.
Studies indicate that 29% to 46% of patients diagnosed with major depressive disorder show partial or no response to treatments.
- November 29, 2021
Resources were based on input from residents in neighborhoods significantly impacted by health disparities and the pandemic.
- November 17, 2021
Columbia Psychiatry is among the principal investigators in biotech Compass Pathways study of more than 200 patients.
- October 27, 2021
This year’s Eric D. Hadar Lecture will take place on November 3, 2021 with Dr. Steven Shoptaw, who will present, “Medications as Foundation for Stimulant Use Disorder Treatment: Is it Time?”
- September 21, 2021
Columbia Psychiatry's Caroline Arout uses quantitative sensory testing, or QST, for assessing the effectiveness of cannabis for therapeutic uses.
- September 15, 2021
Dr. Sidney Hankerson is one of 10 scholars named as 2021’s Emerging Leaders in Health and Medicine by the National Academy of Medicine (NAM).
- September 13, 2021
Ravi N. Shah, MD has been named Chief Innovation Officer for Columbia Psychiatry.
- August 10, 2021
A collaborative study from Columbia University and the Copenhagen Research Centre for Mental Health examines the relationship between Lyme disease and psychiatric outcomes.